It is a prime concern of Evotec that all relevant target groups receive the same information at the same time. This implies communicating in both English and German.

Please find below the most recent corporate news, ad hoc releases and other announcements of our Company.

 

2017

SAMDI Tech, Inc. and Aptuit Announce Drug Discovery Screening Partnership
Nerina Coppini, 7 February 2017

CHICAGO, IL – February 7, 2017 – SAMDI Tech, Inc. and Aptuit, LLC are partnering to broaden their portfolio of assay development and high-throughput drug discovery services in Europe and North America. The partnership provides early-stage drug discovery researchers with access to SAMDI Tech’s unique label-free platform as well as Aptuit’s broad...

2016

Aptuit LLC and Dimension Therapeutics enter strategic partnership to advance select Dimension programs toward IND filing
Nerina Coppini, 7 July 2016

Aptuit Greenwich, CT, and Cambridge, MA - July 7, 2016 – Aptuit LLC, a premier global drug discovery and development CRO, and Dimension Therapeutics, a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting the liver, a key organ for human metabolism, announced today a strategic partnership...

Aptuit announces acquisition of Exquiron Biotech AG
Jim Regan, 21 April 2016

Expands Capabilities in Discovery to Include High Throughput Screening and Other Early Discovery Services Greenwich, CT, April 21st, 2016 - Aptuit, LLC today announced that it has acquired Exquiron Biotech AG to meet customer demand for fully integrated outsourced discovery services. Exquiron is a leading specialist Contract Research...

Aptuit and Icagen agree to strategic alliance
Jim Regan, 22 February 2016

Alliance to Provide Drug Discovery Customers Access to Industry Leading Ion Channel and Transporter Technologies Greenwich, CT, February 22nd, 2016 - Aptuit LLC and Icagen, Inc. today announced a strategic alliance to give drug discovery customers access to ion channel and transporter technologies and expert services.Aptuit LLC, a premier global...

2015

Aptuit announces 16M$ investment in capacity and capability
Jim Regan, 7 December 2015

Significant increase in headcount, new capabilities in discovery and incremental increase in capacity in CMC Greenwich, CT, December 7th, 2015 -  Aptuit LLC announced it has commenced a growth program for 2016 to meet significant increase in demand from our customers in discovery, Chemistry, Manufacturing and Controls (CMC) and non-clinical...

 

Other announcements

Merger

The following annoucement has been published in the German Federal Gazette in accordance with the German Conversion Act (Umwandlungsgesetz) in 2013. Pursuant to the German Conversion Act, certain transaction intended by Evotec AG, e.g. up-stream mergers, have to be announced in the Federal Gazette (Bundesanzeiger).

Contact us

Gabriele Hansen

VP, Corporate Communications & Investor Relations

T +49 40 560 81 255 F +49 40 560 81 333 vCard

Katja Werner

Investor Relations Associate

T +49 40 560 81 210 F +49 40 560 81 333 vCard